Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium-Reference-Cited by-同舟云学术

Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium

Published:2015-12 Issue: Volume:201 Page:517-528
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Suresh Sumanth C.,Selvaraju Vaithinathan,Thirunavukkarasu Mahesh,Goldman Joshua W.,Husain Aaftab,Alexander Palesty J.,Sanchez Juan A.,McFadden David W.,Maulik Nilanjana^ORCID

Funder

Cardiovascular Research Fund

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference48 articles.

1. Bone marrow cells regenerate infarcted myocardium;Orlic;Nature,2001

2. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium;Pasha;Cardiovasc. Res.,2008

3. Regenerating new heart with stem cells;Anversa;J. Clin. Invest.,2013

4. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure;Fisher;Cochrane Database Syst. Rev.,2014

5. Cell therapy, a novel remedy for dilated cardiomyopathy? A systematic review;Gho;J. Card. Fail.,2013

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manufacturing mesenchymal stromal cells in a microcarrier-microbioreactor platform can enhance cell yield and quality attributes: case study for acute respiratory distress syndrome;Journal of Translational Medicine;2024-07-02

2. Mimicking physiological stiffness or oxygen levels in vitro reorganizes mesenchymal stem cells machinery toward a more naïve phenotype;2024-06-12

3. The cold‐inducible RNA‐binding protein—Thioredoxin 1 pathway ameliorates mitochondrial dysfunction and mitochondrial dynamin‐related protein 1 level in the hippocampus of aged mice with perioperative neurocognitive dysfunction;CNS Neuroscience & Therapeutics;2023-08-29

4. Targeted cell delivery of mesenchymal stem cell therapy for cardiovascular disease applications: a review of preclinical advancements;Frontiers in Cardiovascular Medicine;2023-08-04

5. Inorganic nanoparticle‐integrated mesenchymal stem cells: A potential biological agent for multifaceted applications;MedComm;2023-07-31